Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
MDL 28170: A Causal Calpain Assay Strategy
2026-08-11
MDL 28170 is a cell-permeable calpain inhibitor that helps distinguish protease-driven injury from downstream neuronal and cellular consequences. This guide develops an assay-first framework using the BDNF/TrkB findings from a recent neurodevelopmental study and extends interpretation to cardiac and parasitology models.
-
Ferrocenyl Novobiocin Derivatives: Study Insights
2026-08-11
The reference study developed paired organic and ferrocenyl novobiocin derivatives and evaluated them against Plasmodium falciparum and a human breast cancer cell line. Its central finding was that ferrocene incorporation generally improved in vitro activity, providing a useful scaffold-design lesson for enzyme-targeted anti-infective and anticancer research while leaving antibacterial translation untested.
-
Homoharringtonine: Mechanism and Research Evidence
2026-08-10
Homoharringtonine is a cytotoxic alkaloid and protein synthesis inhibitor used in leukemia research and cancer biology. Peer-reviewed evidence supports nanomolar SARS-CoV-2 replication inhibition in vitro and exploratory upper-respiratory-tract findings, but these data do not establish a clinical treatment indication.
-
From Pig Biology to Better qPCR Decisions
2026-08-09
A translational analysis of how Eucommia ulmoides research turns phenotype, microbiota, and gene-expression findings into more rigorous qPCR workflows.
-
CGP 55845 Hydrochloride for Synaptic Assays
2026-08-08
Use CGP 55845 hydrochloride to isolate GABAB-dependent components of astrocyte–neuron signaling, presynaptic inhibition, and neurotransmitter release. This workflow translates dentate gyrus GAT-3 findings into controlled in vitro experiments while clearly separating receptor pharmacology from transporter biology.
-
Calnexin Shapes CFTR Variant Rescue by Correctors
2026-08-07
Tedman et al. systematically examined how the ER chaperone calnexin influences expression and pharmacological rescue across 232 clinical CFTR variants. Their deep mutational scanning results show that proteostasis is a major, variant-specific determinant of corrector response, supporting more context-aware approaches to cystic fibrosis research and theratyping.
-
4-Phenylbutyric Acid: Workflow Optimization for ER Stress Mo
2026-08-07
4-Phenylbutyric acid (4-PBA) enables highly reproducible ER stress alleviation and autophagic pathway dissection in advanced cell models. This guide translates recent mechanistic breakthroughs into actionable workflows, troubleshooting, and enhanced assay reliability—anchored by APExBIO’s rigorously validated reagent quality.
-
HotStart™ 2X Green qPCR Master Mix for High-Precision qPCR
2026-08-06
HotStart™ 2X Green qPCR Master Mix delivers highly specific, reproducible SYBR Green qPCR results through antibody-mediated Taq polymerase inhibition. Its robust formulation enables accurate gene expression analysis and nucleic acid quantification across diverse applications.
-
Fe3O4@ZIF-8 Nanoparticles: Antibacterial and Osteogenic Stra
2026-08-06
This study presents a multifunctional nanoplatform—Fe3O4@ZIF-8 nanoparticles—for treating jaw osteomyelitis, combining potent antibacterial effects with bone regeneration capabilities. The findings highlight how controlled Zn2+ release disrupts bacterial membranes and proteostasis, while Fe3O4 supports osteogenesis, offering a promising translational approach to persistent infection and bone defect repair.
-
CGP 55845 Hydrochloride: Precision GABAB Receptor Antagonist
2026-08-05
CGP 55845 hydrochloride empowers researchers to dissect GABAB receptor-mediated neurotransmitter modulation with high specificity in in vitro models. Its robust pharmacology and compatibility with advanced synaptic transmission assays make it an essential tool for unraveling astrocyte-driven mechanisms in the hippocampal dentate gyrus.
-
RNASEH1-AS1: Prognostic lncRNA Target in Hepatocellular Carc
2026-08-05
This study identifies the long non-coding RNA RNASEH1-AS1 as an independent biomarker and oncogenic factor in hepatocellular carcinoma (HCC), highlighting its association with poor prognosis and immune regulation. Comprehensive transcriptomic and experimental analyses reveal RNASEH1-AS1's mechanistic links to cancer progression and its value for future diagnostic and therapeutic strategies.
-
Bioluminescent Probes for Immunoproteasome: Synthesis and As
2026-08-04
The reference study introduces a caged bioluminescent probe selective for the immunoproteasome (iCP), enabling rapid and specific activity assays in live cells. This innovation addresses the need for improved tools to study iCP in disease contexts and facilitates future small-molecule screening and mechanistic research.
-
Applied Workflows with 10 mM dNTP Mixture for DNA Synthesis
2026-08-04
Unlock reproducible, high-fidelity DNA synthesis by leveraging the APExBIO 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture. This guide distills protocol enhancements, troubleshooting, and integrative insights from recent advances in intracellular trafficking and nucleic acid delivery. Empower your PCR, sequencing, and DNA assembly workflows with actionable, evidence-based strategies.
-
Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor Workflows
2026-08-03
Explore how Sitagliptin phosphate monohydrate enables precise incretin hormone modulation and advanced metabolic disease modeling. Discover optimized protocols, troubleshooting strategies, and experimental insights anchored by the latest gut-brain research.
-
D-Luciferin Potassium Salt: Strategic Insights for Translati
2026-08-03
This article delivers a thought-leadership perspective on D-Luciferin (potassium salt) as a pivotal tool for translational researchers. By interweaving mechanistic understanding, experimental design, and clinical relevance, it provides strategic guidance for deploying bioluminescence imaging in advanced disease models—distinguishing itself from standard product overviews.